Cell Source, Inc. (33) | Uncategorized (8)

Recent Contracts

Amendment No. 2 to Sponsored Research Agreement dated October 18, 2021 between the University of Texas MD Anderson Cancer Center and Cell Source Ltd (Filed With SEC on April 15, 2022)
Amendment No. 2 to Sponsored Research Agreement dated October 18, 2021 between The University of Texas M.D. Anderson Cancer Center and Cell Source Limited (Filed With SEC on November 15, 2021)
(Filed With SEC on August 14, 2019)
(Filed With SEC on August 14, 2019)
(Filed With SEC on August 14, 2019)
AMENDMENT NO. 1 TO VETO CELL PRODUCTION AND CLINICAL TRIAL PROGRAM AGREEMENT (Filed With SEC on May 20, 2019)
§ 1 Subject matter (Filed With SEC on April 1, 2019)
SPONSORED RESEARCH AGREEMENT (Filed With SEC on April 1, 2019)